Straumann Holding AG (0QMV.IL)
| Previous close | 1,265.50 |
| Open | 112.60 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 111.90 - 115.64 |
| 52-week range | 97.44 - 210.70 |
| Volume | |
| Avg. volume | 166,079 |
| Market cap | 1.826B |
| Beta (5Y monthly) | 0.96 |
| PE ratio (TTM) | 5.07 |
| EPS (TTM) | 22.40 |
| Earnings date | N/A |
| Forward dividend & yield | 0.68 (0.57%) |
| Ex-dividend date | 07 Apr 2022 |
| 1y target est | N/A |
- Business Wire
CORRECTING and REPLACING, Oral-B and Straumann Partner on a Landmark Alliance for Scientific Education to Improve the Periodontal and Peri-Implant Health of Patients Worldwide
GENEVA & BASEL, Switzerland, June 08, 2022--Please replace the release with the following corrected version due to multiple revisions.
- EQS Group
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Straumann Holding AG / Key word(s): Acquisition/Agreement20-May-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. PlusDental combines consumer marketing expertise with doctor-led treatments, complementing the Group’s strategic priority to invest in the orthodontics segment PlusDental expands Straumann Group’s footprint in the doctor-led consumer orthodontics segment through added market coverage in
- EQS Group
Straumann Group reports very strong first quarter
Straumann Holding AG / Key word(s): Quarter Results/Sustainability 28-Apr-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.Quarterly revenue of CHF 589 million, 27.2% organic revenue growth on previous yearStrong organic double-digit growth in all regions; LATAM fastest-growingLaunch of two innovative challenger brand implants, Neodent Zi and Anthogyr X3Acquisition of a strategic minority stake in
